Chien KS, DeZern AE. The patient voice: measuring what matters in lower-risk myelodysplastic syndromes treated with imetelstat. haematol [Internet]. 2026Jul.1 [cited 2026Jul.9];111(7):2195-8. Available from: https://haematologica.org/article/view/13190